MDF-DTA:一种多维融合方法,用于药物标结合 afinity 预测
Amit Ranjan1, Adam Bess1, Chris Alvin2
1Department of Environmental Sciences, Louisiana State University, Baton Rouge, Louisiana 70803, United States.
Journal of chemical information and modeling
|June 18, 2024
概括
这项研究介绍了药物目标亲和力预测的多维融合 (MDF-DTA),这是一种全新的深度学习模型,通过整合多种药物和目标特征来提高药物发现,从而实现更准确的亲和力预测.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 机器学习在药物发现中的作用
背景情况:
- 药物标亲和力 (DTA) 预测对于有效的药物发现至关重要.
- 由于巨大的化学和基因组空间,传统方法是缓慢和资源密集的.
- 现有的计算模型经常使用药物和目标的有限特征表示.
研究的目的:
- 开发一个先进的深度学习模型,用于增强DTA预测.
- 整合药物和目标的多维特征 (1D,2D,3D).
- 提高识别潜在候选药物的准确性和效率.
主要方法:
- 提出了一个深度学习模型:用于药物目标亲和力预测的多维融合 (MDF-DTA).
- 从药物和目标的预训练模型中合的1D,2D和3D表示.
- 在标准DAVIS和KIBA基准数据集上评估模型.
主要成果:
- 在这两种数据集上,MDF-DTA与最先进的方法相比,表现优越.
- 除研究证实了个体特征表示的意义.
- 该模型有效地整合了各种分子特征尺寸,以改善DTA预测.
结论:
- MDF-DTA为药物向 afinity 预测提供了一种强大而准确的方法.
- 整合多维特征是推动计算药物发现的关键.
- 该模型有可能加速药物开发的早期阶段.
相关概念视频
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Quantitative Aspects of Drug-Receptor Interaction
972
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
972
Protein-Drug Binding: Determination Methods
161
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
161
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K


